Dr Reddys, Emcure Lenacapavir Gets CDSCO Panel Nod for CT, BE Waivers in HIV PrEP Written By Susmita Roy25 Aug 2026 8:00 PM ISTNew Delhi: In a significant regulatory development that could expand access to long-acting HIV prevention in India, pharmaceutical majors Dr. Reddy's...
Aurobindo Pharma Inks Voluntary Licensing Pact with MSD for HIV Prevention Medicine Written By sheeba farhat25 July 2026 6:38 PM ISTNew Delhi: Aurobindo Pharma Limited has entered into a non-exclusive voluntary licensing agreement with MSD (the trade name of Merck & Co., Inc.,...
GSK Halts Cough Drug Camlipixant After Late-Stage Trial Failure Written By sheeba farhat18 July 2026 4:46 PM ISTLondon: GSK will halt development of an experimental drug to treat refractory chronic cough after it failed to meet key goals across two late-stage...
South Africa Pushes for Local Manufacturing of Gilead's HIV Drug Lenacapavir to Boost Access Written By sheeba farhat6 March 2026 10:43 PM ISTLondon: South Africa is asking local drugmakers to start a process to make Gilead Sciences' long-acting HIV prevention drug, lenacapavir,...
USFDA Approves Bionpharma's Generic HIV Drug Etravirine Written By sheeba farhat14 Jan 2026 5:40 PM ISTThe product was developed using STEERLife's FragMelt continuous processing platform, which enables solvent-free manufacturing while maintaining...
HIV drug kickbacks: Gilead Sciences to pay USD 202 million to settle lawsuit Ruchika Sharma1 May 2025 3:15 PM ISTNew York: Gilead Sciences has agreed to pay USD 202 million to settle a whistleblower lawsuit that accused the company of engaging in civil fraud...
Gilead Sciences sets aside USD 200 million to resolve HIV drug investigation Ruchika Sharma4 March 2025 4:00 PM ISTNew York: Gilead Sciences has allocated USD 200 million to potentially settle with federal prosecutors to resolve an investigation into its...
Trump order set to stop supply of HIV, malaria drugs to poor countries: Sources Written By Ruchika Sharma29 Jan 2025 5:33 PM ISTBengaluru: The Trump administration has moved to cease the supply of lifesaving medicines for HIV, malaria and tuberculosis, and medical supplies...
WHO issues warning for growing resistance to HIV drug of GSK Written By Ruchika Sharma11 March 2024 5:58 PM ISTThe World Health Organization (WHO) has said resistance to GSK's HIV drug dolutegravir has exceeded levels observed during its trials, citing...
Health Bulletin 11/ March/ 2024 Roshni Dhar11 March 2024 4:58 PM ISTHere are the top health news for the day:NEET UG 2024 registration deadline extendedThe deadline for NEET 2024 application submissions has been...
WHO warns of growing resistance to GSK HIV drug Written By Ruchika Sharma6 March 2024 12:30 PM ISTThe World Health Organization (WHO) has said resistance to GSK's HIV drug dolutegravir has exceeded levels observed during its trials, citing...
Aurobindo Pharma bags USFDA nod for HIV drug Darunavir Ruchika Sharma29 Nov 2023 2:46 PM ISTHyderabad: Aurobindo Pharma Limited has announced that the Company has received final approval from the US Food & Drug Administration (USFDA) to...
